ABSCI CORP Shareholders' Equity
ABSCI CORP (ABSI) had Shareholders' Equity of $246.13 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $246.13M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $171.97M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $189.45M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $210.34M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $246.13M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $171.97M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $189.45M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $210.34M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $173.37M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $198.80M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $179.13M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $201.34M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $221.49M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $240.11M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $176.18M 10-K · filed 2026-03-24 |
| 2023-09-30 | $196.42M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $215.40M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $253.97M 10-Q · filed 2024-11-12 |
| 2022-12-31 | $274.41M 10-K · filed 2025-03-18 |
| 2022-09-30 | $292.94M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $316.19M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $340.50M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $366.11M 10-K · filed 2024-03-21 |
| 2021-09-30 | $388.01M 10-Q · filed 2022-11-09 |
| 2021-06-30 | -$124.26M 10-Q · filed 2022-11-09 |
| 2021-03-31 | -$98.50M 10-Q · filed 2022-11-09 |
| 2020-12-31 | -$89.43M 10-K · filed 2023-03-30 |
| 2020-06-30 | -$71.88M 10-Q · filed 2021-09-07 |
| 2020-03-31 | -$54.96M 10-Q · filed 2021-09-07 |
| 2019-12-31 | -$41.16M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |